U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Original Source
NVIDIA Recommends Stockholders Reject ‘Mini-Tender’ Offer by Tutanota LLC
SANTA CLARA, Calif., May 27, 2022 (GLOBE NEWSWIRE) — NVIDIARead More
Quanta Services Announces Quarterly Cash Dividend
HOUSTON, May 27, 2022 /PRNewswire/ — Quanta Services, Inc. (NYSE:Read More
Ellen Cooper Assumes Role of Lincoln Financial Group President and Chief Executive Officer
Ellen Cooper assumes the role of president and CEO ofRead More
HII Uses Movie Release to Celebrate Its Workforce
NEWPORT NEWS, Va., May 27, 2022 — With HII-built aircraftRead More
Kimberly-Clark Celebrates Menstrual Hygiene Day, Highlights Global Efforts to Fight Period Stigma
Global menstrual health and hygiene programs benefitted 8.7 million peopleRead More
Marcos Purty Will Return to GM to Lead Global Workplace Safety
General Motors announced today Marcos Purty will be appointed viceRead More
Autodesk to Present at Upcoming Investor Conferences
SAN FRANCISCO , May 27, 2022 /PRNewswire/ — Autodesk, Inc.Read More
The Champions League: How media rights deals are shaping the global soccer landscape
The Union of European Football Associations (UEFA) Champions League FinalRead More
Monthly Rebalancing Announced for the S&P/NZX New Zealand Fixed Interest Index Series
S&P Dow Jones Indices announced the June 2022 rebalancing resultsRead More
Citi Hires Veteran-Owned Firms Exclusively to Lead Manage Recent $2.0 Billion Bond Issuance
NEW YORK – Citi today announced that it worked exclusivelyRead More
The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Risankizumab (SKYRIZI®) in Crohn's Disease
NORTH CHICAGO, Ill., May 27, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV)Read More